NPI: 1467414623 · WOODBURN, OR 97071 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/04/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/04/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 13,330 | $378K |
| 2019 | 25,333 | $934K |
| 2020 | 23,587 | $292K |
| 2021 | 14,347 | $359K |
| 2022 | 16,007 | $508K |
| 2023 | 6,646 | $326K |
| 2024 | 2,815 | $247K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 40,433 | 2,340 | $2.99M |
| J1270 | Injection, doxercalciferol, 1 mcg | 14,970 | 897 | $22K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 30,235 | 1,203 | $13K |
| J1756 | Injection, iron sucrose, 1 mg | 3,854 | 789 | $9K |
| A4657 | Syringe, with or without needle, each | 6,655 | 2,014 | $7K |
| 83970 | 1,193 | 750 | $1K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 377 | 199 | $518.79 |
| 82728 | 502 | 325 | $116.71 | |
| 83550 | 515 | 334 | $83.52 | |
| 85041 | 1,346 | 831 | $73.07 | |
| 85048 | 1,369 | 830 | $67.25 | |
| 83540 | 514 | 333 | $61.85 | |
| 82108 | 64 | 46 | $21.68 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 38 | 25 | $0.00 |